These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 8821547)
1. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Hu DE; Hiley CR; Fan TP Br J Pharmacol; 1996 Feb; 117(3):545-551. PubMed ID: 8821547 [TBL] [Abstract][Full Text] [Related]
2. Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers. Hu DE; Hiley CR; Smither RL; Gresham GA; Fan TP Lab Invest; 1995 May; 72(5):601-10. PubMed ID: 7538184 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Fan TP; Hu DE; Guard S; Gresham GA; Watling KJ Br J Pharmacol; 1993 Sep; 110(1):43-9. PubMed ID: 7693287 [TBL] [Abstract][Full Text] [Related]
4. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats. Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721 [TBL] [Abstract][Full Text] [Related]
5. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Hu DE; Fan TP Br J Pharmacol; 1995 Jan; 114(2):262-8. PubMed ID: 7533611 [TBL] [Abstract][Full Text] [Related]
6. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Walsh DA; Hu DE; Wharton J; Catravas JD; Blake DR; Fan TP Br J Pharmacol; 1997 Apr; 120(7):1302-11. PubMed ID: 9105706 [TBL] [Abstract][Full Text] [Related]
7. Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells. Pönicke K; Heinroth-Hoffmann I; Becker K; Brodde OE Br J Pharmacol; 1997 May; 121(1):118-24. PubMed ID: 9146895 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Douglas SA; Hiley CR Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174. Widdop RE; Gardiner SM; Kemp PA; Bennett T Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980 [TBL] [Abstract][Full Text] [Related]
10. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866 [TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats. Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760 [TBL] [Abstract][Full Text] [Related]
12. The effect of stress and in vivo vasoactive intestinal peptide (VIP) treatment on the response of isolated rat aorta to norepinephrine, angiotensin II and vasopressin, and adventitial mast cells. Tunçel N; Erkasap N; Sahintürk V Stress; 2000 Nov; 3(4):299-308. PubMed ID: 11342395 [TBL] [Abstract][Full Text] [Related]
13. [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats. Hu DE; Fan TP Br J Pharmacol; 1993 May; 109(1):14-7. PubMed ID: 7684297 [TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog. Clark KL; Robertson MJ; Drew GM Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237 [TBL] [Abstract][Full Text] [Related]
15. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats. Gardiner SM; Kemp PA; March JE; Bennett T Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510 [TBL] [Abstract][Full Text] [Related]
16. VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats. Alexander LD; Sander LD Regul Pept; 1995 Nov; 59(3):321-33. PubMed ID: 8577937 [TBL] [Abstract][Full Text] [Related]
17. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366 [TBL] [Abstract][Full Text] [Related]
18. Characterization of contractile response to angiotensin in epididymal rat vas deferens. Sum CS; Cheung WT Pharmacology; 1995 Aug; 51(2):105-11. PubMed ID: 8584570 [TBL] [Abstract][Full Text] [Related]
19. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats. Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Hori Y; Hu DE; Yasui K; Smither RL; Gresham GA; Fan TP Br J Pharmacol; 1996 Aug; 118(7):1584-91. PubMed ID: 8842418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]